PERCEIVE-Outreach Program for Long COVID Heart and Lung Issues
PERCEIVE-Outreach: A Scalable, Risk-Based Model for Managing Persistent Cardiovascular Impact in Long COVID
Recruiting
N/A
Interventional Study
Long COVID
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 40 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 577 (estimated)
- Sponsor
- University of Tasmania · Other
Who this trial is looking for
This trial is looking for people over 40 who have ongoing symptoms from COVID-19 that affect their heart or lungs. Participants will go through a simple assessment and receive a personalized exercise program, all conducted from home via telehealth.
Are You a Good Fit for This Trial?
You may be able to join if
- I am 40 years old or older
- I have symptoms like fatigue, shortness of breath, or chest pain
- I have had COVID-19
- I am eligible for Medicare
- I can give written consent to participate
- I can communicate clearly with the study team
You may not be able to join if
- I cannot give written consent
- I am in another research trial
- I have a mobility impairment that affects my ability to exercise
- I have a history of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
- I have severe heart issues or previous heart failure
- I have a life expectancy of less than 12 months
- I am pregnant
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
Some people who had COVID-19 continue to have symptoms for weeks, months, or even years after their infection. This is often called "Long COVID" or Post-Acute Sequelae of SARS-CoV-2 (PASC). For some people, Long COVID can affect the heart and lungs, making it harder to exercise or carry out daily activities. It can also affect mental health and quality of life.
This study is testing a new care mo…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Aged forty years or older
* Impaired estimated functional capacity using DASI as proxy (defined by age-normative metabolic equivalent of tasks \[METs\])
* History of COVID-19 (stratified by hospital admission)
* Currently symptomatic with fatigue, dyspnoea or chest pain sympto…
Contacts